Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Longerich

Showing results (141-150 of 227) with videos related to

Pageof 23
Sort By:
Journal of Clinical Medicine|October 18, 2019
Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular CarcinomaVladimir J Lozanovski, Larissa T B Kerr, Elias Khajeh, et al.
Plos One|October 21, 2014
Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinomaStefan Welte, Toni Urbanik, Christin Elßner, et al.
Redox Biology|October 8, 2022
Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expressionAthanassios Fragoulis, Julia Schenkel, Nicole Schröder, et al.
Cell Death & Disease|April 3, 2020
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD miceFranziska Wandrer, Stephanie Liebig, Silke Marhenke, et al.
Hepatology (Baltimore, Md.)|January 8, 2014
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinomaTony Gutschner, Monika Hämmerle, Nikolaos Pazaitis, et al.
Oncotarget|June 23, 2018
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastasesSven H Loosen, Frank Tacke, Marcel Binnebosel, et al.
Scientific Reports|May 25, 2017
The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cellsLinda Nötzold, Lukas Frank, Minakshi Gandhi, et al.
Targeted Oncology|February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World DataAlexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Surgical Innovation|February 7, 2012
Early detection of metabolic changes using microdialysis during and after experimental kidney transplantation in a porcine modelHamidreza Fonouni, Majid Esmaeilzadeh, Parvin Jarahian, et al.
Radiation Oncology (London, England)|February 19, 2025
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancerPaula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, et al.
Pageof 23

Showing results (141-150 of 227) with videos related to

Sort By:
Pageof 23
Journal of Clinical Medicine|October 18, 2019
Liver Grafts with Major Extended Donor Criteria May Expand the Organ Pool for Patients with Hepatocellular CarcinomaVladimir J Lozanovski, Larissa T B Kerr, Elias Khajeh, et al.
Plos One|October 21, 2014
Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinomaStefan Welte, Toni Urbanik, Christin Elßner, et al.
Redox Biology|October 8, 2022
Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expressionAthanassios Fragoulis, Julia Schenkel, Nicole Schröder, et al.
Cell Death & Disease|April 3, 2020
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD miceFranziska Wandrer, Stephanie Liebig, Silke Marhenke, et al.
Hepatology (Baltimore, Md.)|January 8, 2014
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinomaTony Gutschner, Monika Hämmerle, Nikolaos Pazaitis, et al.
Oncotarget|June 23, 2018
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastasesSven H Loosen, Frank Tacke, Marcel Binnebosel, et al.
Scientific Reports|May 25, 2017
The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cellsLinda Nötzold, Lukas Frank, Minakshi Gandhi, et al.
Targeted Oncology|February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World DataAlexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Surgical Innovation|February 7, 2012
Early detection of metabolic changes using microdialysis during and after experimental kidney transplantation in a porcine modelHamidreza Fonouni, Majid Esmaeilzadeh, Parvin Jarahian, et al.
Radiation Oncology (London, England)|February 19, 2025
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancerPaula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, et al.
Pageof 23